Epidemiology of tuberculous lymphadenitis in Denmark: A nationwide register-based study
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Tuberculous lymphadenitis (TBLA) is the most common extrapulmonary manifestation of tuberculosis (TB), often claimed to be reactivation. We aimed to describe the epidemiology of TBLA in Denmark, as it has not previously been investigated specifically although extrapulmonary TB has been associated with an increased long-term mortality and delays in the diagnosis. METHODS: Register-based study of all patients notified with TBLA in Denmark from 2007 through 2016 utilizing six different nationwide registers. Patients were identified through the national TB surveillance register, and the diagnosis evaluated based on microbiology, pathology and/or clinical assessment. RESULTS: In total, 13.5% (n = 489) of all TB patients in Denmark had TBLA with annual proportions from 9.4 to 15.7%. Most patients were immigrants between 25-44 years. Incidence rates ranged from as high as 1,014/100,000 for Nepalese citizens to as a low as 0.06/100,000 for Danes. Danes had a significant higher median age and significant more risk factors and comorbidities, as well as an increased overall mortality, compared with immigrants (p<0.05). A significant and much higher proportion of unique MIRU-VNTR genotypes were seen among TBLA patients compared to other TB manifestations. CONCLUSION: In Denmark, TBLA is a common manifestation of TB, especially in young immigrants from high-incidence countries. In Danes, it is a rare disease manifestation and associated with higher morbidity and mortality. To our knowledge, this is the first study suggesting that TBLA is predominantly associated with reactivation of latent TB infection based on genotyping although this remains to be clarified.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Fig 3 Country and regions of origin. A) The number of tuberculous lymphadenitis patients from the 15 most frequent countries of origin, B) Patient origin by WHO regions in percentages. Of notice, Somalia and the northern parts of Africa is by WHO included in the Eastern Mediterranean region [19]. Classification of countries by WHO regions is available in the S2 Table.](https://figures.cochat.ai/paper-figures/e8f38552af424c3ba10533c435c9f957/epidemiology-of-tuberculous-lymphadenitis-in-denmark-a-nationwide-register-based-figure-3.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Elm, E. V., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., & Vandenbroucke, J. P. (2007) · BMJ · doi:10.1136/bmj.39335.541782.ad · Cited by 10,766 · cited 5×
“Countries were categorized by regions according to WHO definitions (Listed in S2 Table) [19].”
InfluentialThe Danish National Patient Registry: a review of content, data quality, and research potential
Schmidt, M., Schmidt, S. A. J., Sandegaard, J. L., Ehrenstein, V., Pedersen, L., & Sørensen, H. T. (2015) · Clinical Epidemiology · doi:10.2147/clep.s91125 · Cited by 4,769
The Danish Civil Registration System as a tool in epidemiology
Schmidt, M., Pedersen, L., & Sørensen, H. T. (2014) · European Journal of Epidemiology · doi:10.1007/s10654-014-9930-3 · Cited by 3,441
Murray, D. D., Suzuki, K., Law, M., Trebicka, J., Neuhaus, J., Wentworth, D., Johnson, M., Vjecha, M. J., Kelleher, A. D., Emery, S., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0139981 · Cited by 2,740
The Danish Register of Causes of Death
Helweg-Larsen, K. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494811399958 · Cited by 1,732
Bjerregaard, B., & Larsen, O. B. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494810393563 · Cited by 404
Q fever in humans and farm animals in four European countries, 1982 to 2010
Georgiev, M., Afonso, A., Neubauer, H., Needham, H., Thiéry, R., Rodolakis, A., Roest, H. J., Stärk, K. D., Stegeman, J. A., Vellema, P., et al. (2013) · Eurosurveillance · doi:10.2807/ese.18.08.20407-en · Cited by 315
Current diagnosis and management of peripheral tuberculous lymphadenitis.
Fontanilla, J.-M., Barnes, A., & von Reyn, C. F. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir454 · Cited by 299 · cited 4×
“Symptoms are vague and the potential differential diagnoses many [3].”
InfluentialExtrapulmonary tuberculosis in the European Union and European Economic Area, 2002 to 2011
Sandgren, A., Hollo, V, & van der Werf, M. J. (2013) · Eurosurveillance · doi:10.2807/ese.18.12.20431-en · Cited by 238 · cited 2×
“From 2002 through 2011, the proportion of extrapulmonary tuberculosis (EPTB) has increased in the European Union [1].”
Christensen, Johansen, M., Christiansen, C., Jensen, & Lemeshow (2011) · Clinical Epidemiology · doi:10.2147/clep.s20247 · Cited by 203 · cited 1×
“We calculated a modified Charlson Comorbidity Index (CCI) score as a measure of comorbidity based on 19 conditions classified by International Diseases Classification (ICD-8/10) codes from 1977 until the date of disease notification [20].”
Cited by
Ladumor, H., Al‐Mohannadi, S., Ameerudeen, F. S., Ladumor, S. B., & Fadl, S. (2021) · Clinical Imaging · doi:10.1016/j.clinimag.2021.02.012 · Cited by 81
Sharma, A., Rosa, M. D., Singla, N., Singh, G., Barnwal, R. P., & Pandey, A. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01833 · Cited by 64
Clinical features of tuberculous lymphadenitis in a low-incidence country
Mathiasen, V. D., Andersen, P. H., Johansen, I. S., Lillebaek, T., & Wejse, C. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.07.011 · Cited by 56
Self-citationWhat pulmonologists need to know about extrapulmonary tuberculosis
Natali, D., Cloatre, G., Brosset, C., Verdalle, P., Fauvy, A., Massart, J.-P., Van, Q. V., Gerard, N., Dobler, C. C., & Hovette, P. (2020) · Breathe · doi:10.1183/20734735.0216-2020 · Cited by 34
“Concomitant active pulmonary involvement is rare [43].”
Long-term risk of tuberculosis among migrants according to migrant status: a cohort study
Kristensen, K. L., Ravn, P., Petersen, J. H., Hargreaves, S., Nellums, L. B., Friedland, J. S., Andersen, P. H., Nørredam, M. L., & Lillebæk, T. (2020) · International Journal of Epidemiology · doi:10.1093/ije/dyaa063 · Cited by 26
Self-citationAssefa, W., Eshete, T., Solomon, Y., & Kassaye, B. M. (2022) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2022.09.030 · Cited by 16
Bruchfeld, J., Forsman, L. D., Fröberg, G., & Niward, K. (2021) · Springer eBooks · doi:10.1007/978-3-030-66703-0_29 · Cited by 10
Kumbi, H., Ali, M. M., & Abate, A. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-09554-z · Cited by 7
“It is often caused by reactivation of latent infection and is the most common manifestation of extrapulmonary tuberculosis (EPTB) [2, 3].”
BackgroundTuberculous lymphadenitis: a forgotten and delayed diagnosis in low-incidence countries
Dahl, V. N., Lillebæk, T., & Wejse, C. M. (2021) · Infection · doi:10.1007/s15010-021-01632-7 · Cited by 4
Self-citationExtrapulmonalis tuberculosis – diagnosztikai és terápiás kihívás
Sárközi, H.-K., Ianoși, M.-B., Ciurba, B. E., László, N., Sárközi, T., & Jimborean, G. (2022) · Orvosi Hetilap · doi:10.1556/650.2022.32437 · Cited by 3
Valarezo-Sevilla, D., Restrepo-Rodas, G., & Sarzosa-Terán, V. (2020) · Bionatura · doi:10.21931/rb/2020.05.01.10 · Cited by 3
Evaluation of Recurrent Lymphadenitis after Six Months Anti-Tuberculous Therapy
Chowdhury, M. M. H., Chowdhury, M. A. J., Kamal, S. M. M., Anam, M. K., Khan, M., & Zohura, F. T. (2023) · Journal of Bangladesh College of Physicians and Surgeons · doi:10.3329/jbcps.v41i4.68925 · Cited by 1
Qiu, D., Ma, J., Liu, Z., & Zeng, X. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1586938 · Cited by 1
Revisiting Scrofula: An Entity Not to Forget in Migrants’ Health
Neves, S., & Santos, F. V. (2023) · Cureus · doi:10.7759/cureus.40012 · Cited by 1
“This lack of awareness can lead to delays in appropriate treatment, potentially increasing the morbidity and mortality of affected patients, some of whom might end up becoming an active source of transmission in the community through concomitant pulmonary involvement [3].”
BackgroundResultInfluentialChoe, J., Han, A.-R., Shin, S. H., Lee, K., Um, S., Kim, H., Kim, T. Y., Huh, H. J., Choi, Y., Han, J., et al. (2023) · Journal of Korean Medical Science · doi:10.3346/jkms.2023.38.e348 · Cited by 2
“30,31 As in previous studies, mediastinal LNTB in our study was accompanied by pulmonary TB in 35% of patients.”
MethodChowdhury, M. A. I. (2023) · Journal of Bangladesh College of Physicians and Surgeons · doi:10.3329/jbcps.v41i4.69148
“In a Danish reported including more than 480 patients with TB between 2007 and 2016, lymphadenitis was observed in 13.5 percent of cases 7 .”
BackgroundInfluentialPrecision of tuberculosis diagnosis codes in the Central Denmark Region
Dahl, V. N., Moestrup, P. G., Koch, A., Folkvardsen, D. B., Rudolf, F., Gissel, T. N., & Fløe, A. (2025) · Danish Medical Journal · doi:10.61409/a12240847
Gürcüoğlu, E. (2025) · The European Research Journal · doi:10.18621/eurj.1797106
Su, D., Chen, P., Zhang, Y., Wang, Y., & Yang, G. (2026) · BMC Medical Imaging · doi:10.1186/s12880-026-02403-2
“This mismanagement may result in increased morbidity and mortality, as well as the risk of TB transmission from undiagnosed pulmonary TB patients with co-infection [7].”
Diagnosis of tuberculous lymphadenopathy: the role of droplet digital PCR
Wei, Y.-F., Chen, C.-Y., Wang, P.-H., Kuo, Y.-W., Chin-Chung, S., & Yan, B.-S. (2026) · Journal of Global Health · doi:10.7189/jogh.16.04244
Metadata
- Authors
- Mathiasen, V. D., Eiset, A. H., Andersen, P. H., Wejse, C., & Lillebaek, T.
- Affiliations
- Aarhus University (DK)
- Statens Serum Institut (DK)
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2019-08-15
- Volume
- 14
- Issue
- 8
- Pages
- e0221232
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC6695100
- OpenAlex
- W2968324666
- Cited by
- 21
- References
- 35
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 1 · 2023: 5 · 2022: 2 · 2021: 4 · 2020: 4
- FWCI
- 1.92
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Aarhus Universitet
- Familien Hede Nielsens Fond
- Statens Serum Institut
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Infectious Diseases › Diagnosis and treatment of tuberculosis
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Keywords
- tuberculous lymphadenitis, extrapulmonary tuberculosis, tuberculosis epidemiology, immigrants, MIRU-VNTR genotyping, tuberculosis mortality, incidence, Denmark
- MeSH terms
- Adolescent, Adult, Aged, Denmark, Female, Genotype, Humans, Male, Middle Aged, Mycobacterium tuberculosis, Registries, Tuberculosis, Lymph Node, Incidence, Emigrants and Immigrants, Latent Tuberculosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.